Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Queen's University

$24,000.00

Oviductal regulation of gamete interaction and reproductive function

EF 2017-18

Résumé
The mammalian oviduct undergoes physiological and biochemical modifications during late follicular development and estrus. These hormonally regulated changes optimize the oviductal microenvironment for fertilization and early embryonic development. A major glycoprotein secreted by oviductal cells, known as oviductin, is conserved across a number of mammalian species. In the hamster model used in our laboratory, oviductin is an O-glycosylated protein that undergoes cyclic variation of glycosylation during the estrous cycle. We have published extensively on the biosynthesis, secretion, localization and biochemical properties of hamster oviductin (HamOVGP1). During the tenure of my last NSERC DG, we demonstrated, for the first time, the ability of HamOVGP1 to enhance capacitation by potentiating tyrosine phosphorylation of a subset of sperm proteins known to play specific roles in sperm function. Our results further support an important role for oviductin in the oviductal milieu during the early events of fertilization. Recently, we have successfully produced recombinant hamster oviductin (rHamOVGP1) in HEK293 cells. Our recent work supported by NSERC reaffirms our laboratory in the forefront and as an authority in the field of mammalian oviductin. Based on our previous studies showing localization of oviductin to the cell surface of a subpopulation of epithelial cells of the hamster endometrium, we hypothesize that a putative oviductin receptor is present at the cell surface of certain uterine cells and that this receptor may play an important role in uterine receptivity. We plan 1) to examine the role of glycocomponents of rHamOVGP1 in enhancing sperm capacitation through enhancement of tyrosine phosphorylation of sperm proteins, and to assess the effect of glycan and glycopeptide derivatives of rHamOVGP1 in sperm-egg binding and fertilization; 2) to determine the mechanism of how rHamOVGP1 mediates signal transduction pathways that regulate protein tyrosine phosphorylation, and 3) to identify and characterize hamster oviductin receptor and to produce recombinant receptor for testing its possible role in uterine receptivity. To date, the mechanism of oviductin regulating the enhancement of capacitation and sperm-egg binding remains an enigma. Using the rHamOVGP1 that we successfully produced during the tenure of my last NSERC DG, it is now possible to unravel the mechanism of oviductin that regulates some of the key events that lead to successful fertilization and the possible role of oviductin in early implantation. It is anticipated that results obtained from this study will lead to the development of a suitable ""drug cocktail"" therapy utilizing oviductin and its glycan derivatives for improving the insemination procedures involving farm animals in the Canadian agriculture industry as well as IVF procedures involving rodents in research laboratories.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2015-04943
Name nom
Kan, Frederick
Department département
Biomedical and Molecular Sciences - Biomedical and Molecular Sciences
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2015
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
3
Nb partie
5
Application title
Oviductal regulation of gamete interaction and reproductive function
Keyword
NSERC
Application summary
The mammalian oviduct undergoes physiological and biochemical modifications during late follicular development and estrus. These hormonally regulated changes optimize the oviductal microenvironment for fertilization and early embryonic development. A major glycoprotein secreted by oviductal cells, known as oviductin, is conserved across a number of mammalian species. In the hamster model used in our laboratory, oviductin is an O-glycosylated protein that undergoes cyclic variation of glycosylation during the estrous cycle. We have published extensively on the biosynthesis, secretion, localization and biochemical properties of hamster oviductin (HamOVGP1). During the tenure of my last NSERC DG, we demonstrated, for the first time, the ability of HamOVGP1 to enhance capacitation by potentiating tyrosine phosphorylation of a subset of sperm proteins known to play specific roles in sperm function. Our results further support an important role for oviductin in the oviductal milieu during the early events of fertilization. Recently, we have successfully produced recombinant hamster oviductin (rHamOVGP1) in HEK293 cells. Our recent work supported by NSERC reaffirms our laboratory in the forefront and as an authority in the field of mammalian oviductin. Based on our previous studies showing localization of oviductin to the cell surface of a subpopulation of epithelial cells of the hamster endometrium, we hypothesize that a putative oviductin receptor is present at the cell surface of certain uterine cells and that this receptor may play an important role in uterine receptivity. We plan 1) to examine the role of glycocomponents of rHamOVGP1 in enhancing sperm capacitation through enhancement of tyrosine phosphorylation of sperm proteins, and to assess the effect of glycan and glycopeptide derivatives of rHamOVGP1 in sperm-egg binding and fertilization; 2) to determine the mechanism of how rHamOVGP1 mediates signal transduction pathways that regulate protein tyrosine phosphorylation, and 3) to identify and characterize hamster oviductin receptor and to produce recombinant receptor for testing its possible role in uterine receptivity. To date, the mechanism of oviductin regulating the enhancement of capacitation and sperm-egg binding remains an enigma. Using the rHamOVGP1 that we successfully produced during the tenure of my last NSERC DG, it is now possible to unravel the mechanism of oviductin that regulates some of the key events that lead to successful fertilization and the possible role of oviductin in early implantation. It is anticipated that results obtained from this study will lead to the development of a suitable ""drug cocktail"" therapy utilizing oviductin and its glycan derivatives for improving the insemination procedures involving farm animals in the Canadian agriculture industry as well as IVF procedures involving rodents in research laboratories.